Treatment as Prevention¨

Treatment as Prevention named in Time Magazine’s “Top 10 Medical Breakthroughs of 2011”

The treatment of HIV has come a long way, thanks to antiretroviral (ARV) drugs that can lower levels of the virus in the body, keeping people healthy and reducing the risk of HIV transmission. Increasingly, though, studies have also shown that the same drugs used to treat existing infections can also help protect HIV-free people […]

Treatment as Prevention named in Time Magazine’s “Top 10 Medical Breakthroughs of 2011” Read More »

U.S. Secretary of State Hillary Clinton endorses the made-in-BC Strategy of Treatment as Prevention

U.S. Secretary of State Hillary Clinton announced today that “Treatment as Prevention” is integral to the global fight against HIV/AIDS. “Let’s end the old debate over treatment versus prevention and embrace treatment as prevention,” she said this morning in Washington, D.C. Clinton emphasized that effective drug treatment is key to preventing further transmission of HIV

U.S. Secretary of State Hillary Clinton endorses the made-in-BC Strategy of Treatment as Prevention Read More »

A global plea for treatment

The clock is ticking. Dr. Julio Montaner, the world-renowned HIV researcher of the B.C. Centre for Excellence in HIV/AIDS, has made an urgent plea to the medical community to recognize that treating patients with highly active antiretroviral therapy (HAART) doubles as an effective tool against the spread of the incurable virus. Montaner and his team

A global plea for treatment Read More »

Extender la detección precoz y la terapia reduce los contagios de VIH

Extender las pruebas de diagnóstico precoz del VIH y ofrecer fármacos antirretrovirales a todos los seropositivos es la manera más eficaz de contener la epidemia del sida, y a medio plazo tambiŽn la más barata, según ha demostrado Julio Montaner, ex presidente de la Sociedad Internacional del Sida, en una serie de estudios que ha

Extender la detección precoz y la terapia reduce los contagios de VIH Read More »

Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025